Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Ygael Dror"'
Autor:
Sophia Man, Irit Ben-Aharon, Mariana Steiner, Moshe Mishaeli, Katerina Shulman, Sara Morgenstern, Efraim Idelevich, Tal Goshen-Lago, Baruch Brenner, Michal Sternschuss, Lior Soussan-Gutman, Ayala Hubert, Nicky Liebermann, Alexander Beny, Ygael Dror, Ravit Geva
Background Anatomic location of primary tumors across the colon correlate with survival in the metastatic setting, whereas left-sided tumors may exhibit superior survival compared with right-sided tumors. The Oncotype Recurrence Score (RS) assay is a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ba5db310110bff1dd935fb488fdc1ad
https://europepmc.org/articles/PMC6693694/
https://europepmc.org/articles/PMC6693694/
Autor:
Ravit Geva, Ayala Hubert, Alexander Gluzman, Baruch Brenner, Ygael Dror, Einat Shacham-Shmueli, Lior Soussan-Gutman, Moshe Mishaeli, Ofer Purim, Haluk Tezcan, Alexander Beny, Efraim Idelevich, Sophia Man, Nicky Liebermann, Calvin Chao, Mariana Steiner, Adi Shani, Katerina Shulman, Megan P. Rothney
Publikováno v:
Value in Health. 19(1):82-87
ObjectivesTo evaluate the impact of the 12-gene Colon Cancer Recurrence Score Assay—a clinically validated prognosticator in stage II colon cancer after surgical resection—on adjuvant treatment decisions in T3 mismatch repair proficient (MMR-P) s
Autor:
Mariana Steiner, Ygael Dror, Ofer Purim, Nicky Liebermann, Ayala Hubert, Efraim Idelevich, Alexander Gluzman, Baruch Brenner, Alexander Beny, Katerina Shulman, Shahar Merling, Lior Soussan-Gutman, S. Klang, Einat Shacham-Shmueli, Ravit Geva
Publikováno v:
Journal of Clinical Oncology. 31:e22111-e22111
e22111 Background: The Oncotype DX Colon Cancer Recurrence Score (RS) is a validated prognosticator in stage II colon cancer following surgery. However, the impact of the RS on daily practice is still unclear. Clalit Health Services(CHS) has reimburs
Autor:
Rinat Yerushalmi, Efraim Idelevich, Ygael Dror, Salomon M. Stemmer, Arie Figer, Aaron Sulkes, Baruch Brenner, David Loven, Zeev Dreznik, Israel Nudelman, Adi Shani, Eyal Fenig
Publikováno v:
Journal of Surgical Oncology; Jun2006, Vol. 93 Issue 7, p529-533, 5p